Cumberland Pharmaceuticals (CPIX) Net Margin Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | -237,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -129,731.00 |
| Mar 31, 2026 | -4,505.00 |
| Dec 31, 2025 | 787.00 |
| Sep 30, 2025 | -659.00 |
| Jun 30, 2025 | 441.00 |
| Mar 31, 2025 | 3,304.00 |
| Dec 31, 2024 | 4,916.00 |
| Sep 30, 2024 | -637.00 |
| Jun 30, 2024 | -1,911.00 |
| Mar 31, 2024 | -2,426.00 |
| Dec 31, 2021 | -245.00 |
| Sep 30, 2021 | -226.00 |
| Jun 30, 2021 | -219.00 |
| Mar 31, 2021 | -512.00 |
| Dec 31, 2020 | -1,726.00 |
| Sep 30, 2020 | -1,105.00 |
| Jun 30, 2020 | -50.00 |
| Mar 31, 2020 | -332.00 |
| Dec 31, 2019 | 7,035.00 |
| Sep 30, 2019 | 3,905.00 |